Document:

Unassociated Document

    

      AMENDMENT
        NO. 1 TO CONVERTIBLE DEBENTURE AND SECURITIES PURCHASE
        AGREEMENT

      

      This
        Amendment No. 1 (“Amendment”)
        to the
        Convertible Debenture in the principal amount of $600,000 dated January 29,
        2007
        (the “Convertible
        Debenture”)
        and
        the Securities Purchase Agreement dated January 29, 2007 (the “SPA”),
        is
        made as of April 25, 2007, by and among Cornell Capital Partners, L.P.
        (“Cornell”)
        and
        Falcon Natural Gas Corporation (the “Company”).

       

      WHEREAS,
        the
        Company and Cornell entered into the SPA on January 29, 2007, pursuant to
        which
        the Company issued to Cornell that certain 8% Secured Convertible Debenture,
        denominated No. FNGC-2 due January 29, 2010; 

       

      WHEREAS,
        Cornell
        and the Company have agreed to the provision by Cornell to the Company of
        additional $55,555 in financing pursuant to the same terms as provided in
        the
        Convertible Debenture; and 

       

      WHEREAS,
        in
        response and in accordance with that understanding, the parties to this
        Agreement desire to amend the Convertible Debenture and the SPA.

       

      WHEREAS,
        the
        Company is not currently compliant in its obligations under the Convertible
        Debenture and the SPA with respect to the timely filing of the Company’s reports
        under the Securities Exchange Act of 1934, as amended (the “1934
        Act”)
        and
        Cornell agrees to provide a forbearance to the Company for such
        failure.

       

      NOW
        THEREFORE,
        in
        consideration of the foregoing, and for other good and valuable consideration,
        the receipt and sufficiency of which are hereby acknowledged, the parties
        hereto
        agree as follows:

       

      Section
        1. Amendment
        to the Preface of the Convertible Debenture.
        The
        first two paragraphs of the Convertible Debenture are hereby amended and
        restated in their entirety as follows:

       

      “This
        Convertible Debenture (the “Debenture”)
        is
        issued on January 29, 2007 (the “Closing Date”)
        by
Falcon
        Natural Gas Corporation,
        a
        Nevada corporation (the “Company”),
        to
Cornell
        Capital Partners, LP (together
        with its permitted successors and assigns, the “Holder”)
        pursuant to exemptions from registration
        under
        the Securities Act of 1933, as amended, and pursuant to that certain Securities
        Purchase Agreement dated January 29, 2007 (the “Securities Purchase
        Agreement”).

       

      FOR
        VALUE RECEIVED,
        the
        Company hereby promises to pay to the Holder or its successors and assigns
        the
        principal sum of Six Hundred Fifty-Five Thousand Five Hundred Fifty-Five
        Dollars
        ($655,555) together with accrued but unpaid interest on or before January
        29,
        2010 (the “Maturity
        Date”)
        in
        accordance with the following terms:”

       

      Section
        2. Amendment
        to the Preface of the SPA.
        The
        second paragraph under the recitatitions on the first page of the SPA is
        hereby
        amended and restated in its entirety as follows:

       

      
        
           

        

        
           

          
            

          

        

        
           

        

      

      

       

      “WHEREAS,
        the
        parties desire that, upon the terms and subject to the conditions contained
        herein, the Company shall issue and sell to the Buyer(s), as provided herein,
        and the Buyer(s) shall purchase up to Six Hundred Fifty-Five Thousand Five
        Hundred Fifty-Five Dollars ($655,555) of secured convertible debentures (the
        “Convertible
        Debentures”),
        which
        shall be convertible into shares of the Company’s common stock, par value
        $0.00001 (the “Common
        Stock”)
        (as
        converted, the “Conversion
        Shares”);
        of
        which Six Hundred Thousand Dollars ($600,000) shall be funded within five
        (5)
        business day following the date hereof (the “Closing”),
        and
        Fifty-Five Thousand Five Hundred Fifty-Five Dollars ($55,555) was provided
        on
        April 25, 2007 (the “Second
        Closing,”
and
        together with the Closing, the “Closings”)
        for a
        total purchase price of up to Six Hundred Fifty-Five Thousand Five Hundred
        Fifty-Five Dollars ($655,555), (the “Purchase
        Price”)
        in the
        respective amounts set forth opposite each Buyer(s) name on Schedule I (the
        “Subscription
        Amount”).”

       

      Section
        3. Amendment
        to Section 1(b) of the SPA
        Section
        1(b) of the SPA is hereby amended and restated in its entirety as
        follows:

       

      “.
        .
        .

       

      (b) Closing
        Date.
        The
        closing of the purchase and sale of the Convertible Debentures (the
“Closing”)
        shall
        take place at 10:00 a.m. Eastern Standard Time on the fifth day following
        the
        date hereof, subject to notification of satisfaction of the conditions to
        such
        Closing set forth in Sections 6 and 7 below ( the “Closing
        Date”).
        The
        Closing shall occur on the respective Closing Date at the offices of Yorkville
        Advisors, LLC, 3700 Hudson Street, Suite 3700, Jersey City, New Jersey 07302
        (or
        such other place as is mutually agreed to by the Company and the Buyer).
        The
        Second Closing shall take place at 4:00 p.m. Eastern Standard Time on April
        25,
        2007.”

       

      Section
        4. Amendment
        to Section 4(g) of the SPA
        Section
        4(g) of the SPA is hereby amended and restated in its entirety as
        follows:

       

      “...

       

      (g)
        ...

       

      (iv) Simultaneously
        with the Second Closing, the Company shall pay a fee to the Buyer of $5,555,
        to
        be paid directly from the proceeds of the Second Closing.”

       

      Section
        5. Representations
        and Warranties of the Company.
        Except
        as set forth in this Amendment, the Company hereby represents and warrants
        that,
        as of the date hereof, each of the representations and warranties it made
        in
        Section 3 of the SPA remain in full force and effect.

       

      Section
        6. Additional
        Forbearance
        The
        Company and Cornell hereby acknowledge that the Company has not timely filed
        its
        Annual Report on Form 10-KSB for the year ended December 31, 2006 and,
        therefore, the Company is not currently in compliance with certain of its
        obligations under the Convertible Debenture and SPA with respect to filing
        reports under the 1934 Act. Cornell hereby agrees to waive on a one-time
        basis
        the Company’s default under the Convertible Debenture and SPA with respect to
        the Company’s failure to timely file its Annual Report on Form 10-KSB for the
        year ended December 31, 2006 and agrees to forbear from exercising its
        rights and remedies under the Convertible Debenture, SPA and other Transactions
        Documents executed in connection therewith, if the Company files its Annual
        Report on Form 10-KSB for the year ended December 31, 2006 on or before May
        15, 2007.

       

      
        
           

        

        
          -2-

          
            

          

        

        
           

        

      

      

       

      Section
        7. Effect
        of Amendment.
        Except
        as amended hereby, the Convertible Debenture and the SPA shall continue in
        full
        force and effect and are hereby incorporated herein by this reference. The
        Company affirms that the obligation to repay all amounts related to the
        provision of funds to it by Cornell pursuant to the Second Closing is secured
        by
        the security set forth in Section 1(b) of the Convertible Debenture.
 

       

      Section
        8. Governing Law.
        This
        Amendment shall be governed by and construed under the laws of the State
        of New
        Jersey.  

       

      Section
        9. Titles and Subtitles.
        The
        titles of the sections and subsections of this Amendment are for convenience
        of
        reference only and are not to be considered in construing this
        Amendment.

       

      Section
        10. Counterparts.
        This
        Amendment may be executed in counterparts, each of which shall be deemed
        an
        original, and all of which shall constitute one and the same
        instrument.

       

      IN
        WITNESS WHEREOF,
        the
        parties hereto have caused this Amendment to be signed as of the date first
        set
        forth above.

       

      

      
        	 	 	 	 	 
	CORNELL
                CAPITAL PARTNERS, LP	 	FALCON
                NATURAL GAS CORP. 
	 	
                
                  By:
                    Yorkville Advisors, LLC
Its: Investment
                  Manager

              	 	 	 
	 	 	 	 	 
	By:  	
                /s/
                  Mark Angelo

              	 	By: 	
                /s/
                  Saul S. Deutsch   

              
	 	
                Name:
                  Mark Angelo

                Its:
                  Portfolio Manager

              	 	 	
                Name: Saul S. Deutsch 

                Title: Chief Financial Officer

              
	 	 	 	 	 
	 	 	 	 	 

      

      

      

      
        
           

        

        
          -3-Exhibit 10.9

Dated 28th day of April, 2007

                    Chief Financial Officer Service Contract
                                     between
                             Global Pharmatech, Inc.
                                       and
                                 Zongsheng Zhang

This Contract was made between the following two parties on 28th day of April,
2007:

(1) Global Pharmatech, Inc., duly incorporated under the laws of the State of
Delaware ("Party A"); and

(2) Zongsheng Zhang, ("Party B").

     Both parties have entered into the following agreement through friendly
negotiations on the principle of equality and mutual benefits in order to
confirm and regulate the relationship between Party A as the appointor and Party
B as the appointee in respect of the service.

                              Article 1 Appointment

     1.1 Party A shall appoint Party B as chief financial officer of Party A in
accordance with the terms of this Contract.

     1.2 Party B agrees to be appointed as chief financial officer of Party A in
accordance with the terms of this Contract.

                                Article 2 Duties

     2.1 Party B's duties, powers and responsibilities as Chief Financial
Officer shall be those which are customary for such position, as may be
determined from time to time by CEO of Party A. Party B shall report to CEO, and
agrees to perform and discharge such duties well and faithfully and to be
subject to the supervision and direction of CEO.

     2.2 The position of Chief Financial Officer is a part-time position. Party
B agrees to devote approximately 40 to 60 hours per month or approximately 120
to 180 hours per quarter to work for Party A. Party B will not engage in any
activity that might conflict with the interests of Party A.

     2.3 Party B agrees to abide by the policies and regulations of Party A from
time to time. In addition, Party B confirms that he owes a fiduciary and
diligence obligation to Party A and that he shall not engage in any activities
in competition with Party A's business or carry out any activities detrimental
to the interests of Party A.
<PAGE>
                             Article 3 Service Fees

     3.1 From the Effective Date, the fees to be received by Party B for the
performance of his services under this Contract shall be RMB 10,000.00 per
month, to be paid monthly.

     3.2 Party B shall be granted Party A's stock options, pending approval of
Party A's Board of Directors at the end of the year.

                            Article 4 Non-Competition

     4.1 During the period of appointment with Party A, Party B agrees not to
engage in any business that individually develops any of the products developed
by Party A including all products approved by the FDA, products marketed by
Party A prior to, during, or under development during the period of appointment.
Party B shall be entitled to employment outside of Party A under the terms and
provisions of this clause including, but not limited to, similar companies so
long as any products developed by similar companies are not in direct
competition with Party A's products.

                       Article 5 Confidentiality Liability

     5.1 Party B is aware that he will gain access to secret information
possessed by members of Party A's Group and/or kept in custody by members of
Party A's Group (hereinafter referred to as "Confidential Information") in the
performance of his duties hereunder, including, but not limited to, documents,
materials, data, information, plans and insider information. Party B confirms
that such Confidential Information is solely owned by members of Party A's Group
and/or is kept in custody by members of Party A's Group.

     5.2 Whether during the term of this Contract or within any time after the
termination of Party B's appointment, Party B warrants that (except such
Confidential Information as may be disclosed to the public not in violation of
the confidentiality undertaking under this Contract):

     (a) Party B shall not divulge or disclose the Confidential Information to
any third party in any way, with the exception of any Confidential Information
which Party B must disclose to the relevant employees of members of Party A's
Group and the professional personnel employed by members of Party A's Group for
the performance of his obligations hereunder and any Confidential Information
the disclosure of which is authorized by the board of directors or is ordered by
a court of competent jurisdiction;

     (b) Party B shall not make use of the Confidential Information in any way
for his own benefit or for the benefit of his friends and relatives or any third
party without Party A's permission; and

     (c) Party B shall take all necessary measures to prevent the Confidential
Information from spreading or disclosure to any third party without Party A's
permission.

                                       2
<PAGE>
     5.3 Upon the expiration of this Contract or earlier termination of Party
B's appointment, Party B shall immediately, completely and effectively return to
Party A all the information relating to the business of members of Party A's
Group (including, but not limited to, Party A's documents, personal notes,
records, reports, handbooks, drawings, forms, computer diskettes and tapes)
within Party B's possession or under his control whether or not the same was
originally supplied to Party B by Party A.

                      Article 6 Termination of Appointment

     6.1 When any one of the following events occurs to Party B, the appointment
relationship between Party A and Party B herein shall be immediately and
automatically terminated (unless otherwise decided by the board of directors):

     (a) Party B is prohibited by any laws, regulations, rules, practice
directions or practice rules from taking up the position hereunder or Party B
loses the qualifications required by the position hereunder;

     (b) If due to health reasons, Party B is unable to fully perform his duties
hereunder for three months;

     (c) Party B commits any serious and/or repeated and/or continual breach of
any of Party B's obligations hereunder;

     (d) Party B is guilty of any serious misconduct or serious neglect in the
discharge of Party B's duties hereunder;

     (e) Party B's actions or omissions bring the name or reputation of Party A
or any member of Party A's Group into serious disrepute or prejudices the
business interests of Party A or other members of Party A's Group;

     (f) Party B is or has become of unsound mind or shall be or become a
patient for the purpose of any laws relating to mental health;

     (g) Party B is sued for criminal liability or convicted of any criminal
offence other than an offence which in the reasonable opinion of the board of
directors of Party A does not affect Party B's position as appointed herein
(bearing in mind the nature of the duties to which Party B is appointed and the
capacities in which Party B is appointed);

      (h) Party B is removed from the office of the position by the Board of
Directors of Party A; or

     (i) Party B leaves the service according to the Articles of Incorporation
of Party A.

                                       3
<PAGE>
     6.2 In addition to the aforesaid provisions of Article 6.1, Party A may
also discharge the appointment relationship between Party A and Party B by
giving notice in writing to Party B when any one of the following events occurs:

     (a) Party B is unable to substantially perform his duties hereunder due to
health reasons, within any three-month period for a cumulative total of three
hundred and sixty-five working days. Then, Party A may at any time discharge
Party B from the post by giving Party B a fourteen-day written notice of
discharge.

     (b) Party B is in breach of his obligations or the provisions of this
Contract and does not repent after warning has been given by Party A.

     (c) Damage or loss has been caused to Party A due to Party B's willful or
material default in the performance of his duties hereunder.

     Any delay by Party A in exercising such right of termination shall not
constitute a waiver thereof.

     6.3 If the appointment relationship between both parties herein is
terminated due to the occurrence of any of the events referred to in Article 6.1
or 6.2 above, such termination shall not affect Party A's rights herein against
Party B and the provisions of Articles 4 and 5 hereof shall still be applicable.

     6.4 Party B shall not, during the continuance of his appointment or within
a period of one year after the termination thereof, either on his own behalf or
on behalf of any other person, entice away from any member of Party A's Group
any employee, worker, manager or director of any member of Party A's Group,
whether or not such person would commit any breach of his contract of
appointment with any member of Party A's Group by reason of his leaving service.

                     Article 7 Effectiveness of the Contract

This Contract shall become effective after signing by both parties.

                          Article 8 Additional Clauses

        8.1 The heading of each Article hereof is inserted for the purpose of
convenience only and shall not prejudice the meaning or construction of the
provisions hereof.

        8.2 This Contract shall have two copies. Party A and Party B shall each
hold one copy which shall have the same effect.

In view of the above, Party A and Party B have signed this Contract.

                                       4
<PAGE>
Party A:

For and on behalf of
Global Pharmatech, Inc

Name: /s/ Lianqin Qu
     -------------------------
Title: Chairwoman of the Board

Party B:

/s/ Zongsheng Zhang
------------------------------

                                       5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00122-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00122-of-00352.parquet"}]]